TMPRSS2 and posterior cortical atrophy: This is an important finding, as it brings into focus the importance of patient stratification based on TMPRSS2-ERG fusion positivity, which was not known earlier and thus was not a selection criterion in patient accrual in the previous trials or case studies looking into NSAID efficacy against PCa.